BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18030487)

  • 1. Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.
    Wasmuth S; Bauer D; Steuhl KP; Heiligenhaus A
    Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):443-51. PubMed ID: 18030487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment with antisense oligonucleotides targeting tumor necrosis factor-alpha in herpetic stromal keratitis.
    Wasmuth S; Bauer D; Yang Y; Steuhl KP; Heiligenhaus A
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5228-34. PubMed ID: 14638721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal treatment with antisense oligonucleotides targeting tumor necrosis factor-α in murine herpes simplex virus type 1 retinitis.
    Grajewski RS; Li J; Wasmuth S; Hennig M; Bauer D; Heiligenhaus A
    Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):231-8. PubMed ID: 22072377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
    Bauer D; Lu M; Wasmuth S; Li H; Yang Y; Roggendorf M; Steuhl KP; Heiligenhaus A
    Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):216-25. PubMed ID: 16047184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection.
    Bauer D; Schmitz A; Van Rooijen N; Steuhl KP; Heiligenhaus A
    Immunology; 2002 Sep; 107(1):118-28. PubMed ID: 12225370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Do antisense oligonucleotides improve viral immunopathology?].
    Wasmuth S; Bauer D; Steuhl KP; Heiligenhaus A
    Ophthalmologe; 2005 Mar; 102(3):272-8. PubMed ID: 15340755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines.
    Heiligenhaus A; Li H; Schmitz A; Wasmuth S; Bauer D
    Clin Exp Immunol; 2005 Oct; 142(1):180-7. PubMed ID: 16178874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subconjunctival antisense oligonucleotides targeting TNF-alpha influence immunopathology and viral replication in murine HSV-1 retinitis.
    Li J; Wasmuth S; Bauer D; Baehler H; Hennig M; Heiligenhaus A
    Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1265-73. PubMed ID: 18491128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis.
    Xia L; Zhang S; Zhou J; Li Y
    Mol Vis; 2010 Oct; 16():2071-83. PubMed ID: 21042564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis.
    Bauer D; Wasmuth S; Hennig M; Baehler H; Steuhl KP; Heiligenhaus A
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3188-98. PubMed ID: 19255156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytokine expression in murine cornea tissue during recurrent herpetic stromal keratitis].
    Xia LK; Zhang JS; Chen XL; Wang AY
    Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):403-8. PubMed ID: 15938803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions.
    Twardy BS; Channappanavar R; Suvas S
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8604-13. PubMed ID: 21969295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice.
    Lepisto AJ; Frank GM; Xu M; Stuart PM; Hendricks RL
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3400-9. PubMed ID: 16877409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine expression in murine corneas during recurrent herpetic stromal keratitis.
    Keadle TL; Usui N; Laycock KA; Kumano Y; Pepose JS; Stuart PM
    Ocul Immunol Inflamm; 2001 Sep; 9(3):193-205. PubMed ID: 11815888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
    Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.
    Duan R; Remeijer L; van Dun JM; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):277-84. PubMed ID: 17197544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model.
    Yoon KC; Heo H; Kang IS; Lee MC; Kim KK; Park SH; Cho KO
    Cornea; 2008 May; 27(4):454-60. PubMed ID: 18434850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-Thioguanine Inhibits Herpes Simplex Virus 1 Infection of Eyes.
    Chen D; Liu Y; Zhang F; You Q; Ma W; Wu J; Wu Z
    Microbiol Spectr; 2021 Dec; 9(3):e0064621. PubMed ID: 34730435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.
    Inoue T; Inoue Y; Hayashi K; Yoshida A; Nishida K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
    Cornea; 2002 Jan; 21(1):106-10. PubMed ID: 11805518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dimethylfumarate on experimental HSV-1 necrotizing keratitis.
    Heiligenhaus A; Li H; Wasmuth S; Bauer D
    Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):870-7. PubMed ID: 15241613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.